US PTAB Patent Cases
8,574 decisions indexed
Page 269 of 286 · 8,574 total
Databricks, Inc. v.R2 Solutions LLC
Databricks, Inc. failed to overcome obviousness challenges against R2 Solutions LLC's patent (8190610) regarding MapReduce data grouping. The PTAB denied institution because Petitioner relied on speculative hindsight rather than demonstrating a clear motivation from prior art references like Pike and Chowdhuri.
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
Merck Sharp & Dohme LLC successfully challenged The Johns Hopkins University's patent (11634491) in a PTAB Institution Decision. The Board found reasonable likelihood of success for multiple claims under both anticipation (§ 102) and obviousness (§ 103).
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
Merck Sharp & Dohme LLC successfully challenged The Johns Hopkins University's patent claims regarding MSI-H cancer treatment, leading the PTAB to institute proceedings. The petitioner argued that the claimed methods were anticipated by or obvious over existing prior art, including the MSI-H Study Record and various medical literature.
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
Merck Sharp & Dohme LLC successfully petitioned to institute IPR proceedings against The Johns Hopkins University regarding a patent on immunotherapy methods. The Board found reasonable likelihood of unpatentability under both 102 and 103, primarily based on the MSI-H Study Record.
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
Merck Sharp & Dohme LLC successfully petitioned to institute IPR against The Johns Hopkins University regarding claims related to anti-PD-1 antibody treatment for MSI colorectal cancer. The Board found a reasonable likelihood of success under both 102 and 103 grounds across all 36 claims at issue.
Aptiv Services US, LLC et al. v.Microchip Technology, Inc.
Aptiv Services challenged Microchip Technology's patent (9471074) in an IPR, arguing obviousness over Al-Shyoukh in view of Ivanov and Stanescu. The PTAB institution decision granted the petition, proceeding to trial on 18 claims.
Loco Crazy Good Cookers, Inc. v.North Atlantic Imports, LLC
Loco Crazy Good Cookers challenged North Atlantic Imports' cooking appliance patent on grounds of obviousness and anticipation. The PTAB instituted review, finding a reasonable likelihood that at least one claim would be obvious based on the prior art references. This moves the dispute toward trial preparation in District Court.
AT&T Corp et al. v.Daingean Technologies Ltd.
The PTAB denied institution of IPR against Daingean Technologies' patent, finding that the petitioner failed to prove its sole prior art reference (R2-1702708) was a publicly accessible printed publication.
Under Armour, Inc. v.Athalonz, LLC
Under Armour successfully petitioned the PTAB to institute IPR on claims related to athletic footwear sole technology, arguing they are obvious under 35 U.S.C. § 103. The Board granted institution, adopting key claim constructions and recognizing the validity of multiple prior art combinations cited by the Petitioner.
Under Armour, Inc. v.Athalonz, LLC
The PTAB granted institution of IPR for Under Armour against Athalonz regarding athletic footwear claims. The Board adopted key claim constructions and found a reasonable likelihood of obviousness over the prior art reference 'Won' for several independent claims.
Under Armour, Inc. v.Athalonz, LLC
Under Armour successfully petitioned to institute an IPR against Athalonz, LLC's shoe patent (11,064,760 B2). The Board found a reasonable likelihood of success on obviousness grounds over prior art like Kim and Dufour.
Under Armour, Inc. v.Athalonz, LLC
Under Armour successfully secured institution of IPR against Athalonz's shoe patent (10,674,786), challenging claims 1-8 based on obviousness over prior art like Kim and Dufour.
Under Armour, Inc. v.Athalonz, LLC
Under Armour successfully secured institution of IPR against Athalonz's patent (11,013,291) for athletic footwear. The Board found a reasonable likelihood that the claims are obvious over prior art reference Kim.
Fluidmaster, Inc. v.Danco, Inc. et al.
Fluidmaster successfully petitioned the PTAB against Danco, Inc., leading to the institution of trial on all 14 claims. The Board found sufficient evidence that the patent's features were obvious under 35 U.S.C. § 103 using various prior art references. This decision significantly advances Fluidmaster’s challenge in related district court litigation.
Fluidmaster, Inc. v.Danco, Inc. et al.
Fluidmaster successfully moved forward with its IPR challenge against Danco's patent (9103105) regarding toilet fill valves. The Board granted institution on multiple grounds, setting the stage for a full trial to determine if the claims are unpatentable over prior art combinations.
Fluidmaster, Inc. v.Danco, Inc. et al.
Fluidmaster successfully petitioned the PTAB to institute an IPR against Danco's patent, challenging 20 claims based on obviousness (35 U.S.C. § 103). The Board adopted a narrow claim construction for 'integrally molded with,' defining it as being formed as a single structure.
TESLA, INC. v.iQar Inc.
Tesla Inc.'s IPR against iQar Inc. was instituted by the PTAB, allowing claims related to vehicle power management logic to proceed to trial. The Board found a reasonable likelihood of prevailing on both anticipation (102) and obviousness (103), particularly regarding the combination of prior art references.
Amazon.com, Inc. et al. v.Nokia Technologies Oy
Amazon successfully navigated the institution phase of its IPR against Nokia regarding video coding claims. The Board found a reasonable likelihood that Amazon could prove unpatentability under § 103, leading to the case being instituted for trial.
Amazon.com, Inc. et al. v.Nokia Technologies Oy
Amazon successfully challenged Nokia's patent claims in an IPR proceeding regarding video coding and motion prediction technology. The Board found a reasonable likelihood of prevailing on the grounds of obviousness over prior art, leading to institution.
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
Merck Sharp & Dohme LLC successfully petitioned to institute IPR proceedings against The Johns Hopkins University regarding anti-cancer immunotherapy claims. The Board found sufficient evidence that the MSI-H Study Record anticipates key claims, warranting further trial on grounds of anticipation and obviousness.
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
Merck Sharp & Dohme LLC successfully instituted an IPR against The Johns Hopkins University's patent, challenging claims related to anti-PD-1 antibodies for MSI-high cancer. The Board found sufficient evidence that prior art anticipated and rendered the claims obvious, leading to a trial institution decision.
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
Merck Sharp & Dohme LLC successfully secured institution for its IPR challenge against The Johns Hopkins University regarding oncology/immunotherapy claims. The Board found sufficient evidence to proceed under 35 U.S.C. § 102 and § 103, despite procedural challenges from the Patent Owner.
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
Merck Sharp & Dohme LLC successfully convinced the PTAB to institute IPR proceedings against The Johns Hopkins University regarding anti-cancer therapies using PD-1 blockade. The Board found sufficient evidence that prior art, including the MSI-H Study Record, renders several claims unpatentable.
Mito Red Light, Inc. v.Joovv, Inc.
Mito Red Light, Inc.'s challenge against Joovv, Inc.'s light therapy patent was denied by the PTAB. The Board found that Petitioner failed to establish unpatentability under § 103 using references Dijkstra and Norwood.
Mianyang BOE Optoelectronics Technology Co., Ltd. et al. v.Samsung Display Co., Ltd.
The PTAB decided to institute the IPR proceedings against Patent No. 9,330,593 B2 in the OLED circuitry space. The Board found sufficient showing for institution based on Petitioner's analysis of Tobita as prior art under §102(b).
Teladoc Health, Inc. v.Data Health Partners, Inc.
Teladoc Health's IPR petition against Data Health Partners was denied by the PTAB, failing to establish a reasonable likelihood of prevailing on any claim. The Board adopted the Patent Owner's narrow construction of 'without input from the clients,' reinforcing its exclusion of client-initiated data when generating scores.
SAP America, Inc. v.ISIX IP LLC
The PTAB decided to institute the IPR against ISIX IP LLC's patent (6308178), finding sufficient evidence that SAP America, Inc. had a reasonable likelihood of prevailing on obviousness grounds over prior art references like Brann and Suresh. The Board adopted key claim constructions, notably rejecting the Patent Owner's narrow view of 'application.'
Teladoc Health, Inc. v.Data Health Partners, Inc.
Teladoc Health successfully petitioned the PTAB to institute IPR proceedings against Data Health Partners' patent (US 11144554), challenging its obviousness over multiple prior art references. The Board found reasonable likelihood of prevailing on all grounds, leading to institution for 18 claims.
Ericsson Inc. et al. v.XR COMMUNICATIONS LLC
The PTAB institution decision found a reasonable likelihood of prevailing for the Petitioner in its IPR against XR Communications LLC. The challenge focused on whether multi-beam directed signal systems were unpatentable under 35 U.S.C. § 103 using prior art references Agee and Butler.
Meta Platforms, Inc. v.Sitnet, LLC
Meta Platforms successfully secured institution of its IPR challenge against Sitnet LLC's patent 8249932, challenging claims based on obviousness over prior art. The Board accepted the Petitioner's arguments regarding claim construction and found a reasonable likelihood of prevailing on at least one ground.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.